Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Apple
AAPL
|
+$3.33B |
| 2 |
NVIDIA
NVDA
|
+$1.99B |
| 3 |
Visa
V
|
+$1.04B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.04B |
| 5 |
Amazon
AMZN
|
+$964M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.52B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.07B |
| 4 |
iShares MSCI India ETF
INDA
|
+$871M |
| 5 |
CrowdStrike
CRWD
|
+$796M |
Sector Composition
| 1 | Technology | 21.76% |
| 2 | Consumer Discretionary | 9.86% |
| 3 | Financials | 9.03% |
| 4 | Healthcare | 6.97% |
| 5 | Industrials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $626K | ﹤0.01% |
15,156
+7,494
| +98% | +$310K |
|
|
HUYA
4227
Huya Inc
HUYA
$769M
| $625K | ﹤0.01% |
158,317
-102,688
| -39% | -$406K |
|
4228
ProShares Smart Materials ETF
TINT
$1.65M
| $624K | ﹤0.01% |
18,840
+251
| +1% | +$8.32K |
|
4229
Sun Communities
SUI
$16B
| $624K | ﹤0.01% |
5,184
-26,920
| -84% | -$3.24M |
|
4230
Franklin Disruptive Commerce ETF
BUYZ
$8.96M
| $623K | ﹤0.01% |
19,913
+6,535
| +49% | +$205K |
|
4231
SPDR ICE Preferred Securities ETF
PSK
$836M
| $623K | ﹤0.01% |
18,355
+10,046
| +121% | +$341K |
|
4232
VanEck Moody's Analytics IG Corporate Bond ETF
MIG
$13.1M
| $623K | ﹤0.01% |
29,623
+9,961
| +51% | +$209K |
|
|
OGSP
4233
Obra High Grade Structured Products ETF
OGSP
$29.6M
| $621K | ﹤0.01% |
+61,644
| New | +$621K |
|
4234
Cambria Tail Risk ETF
TAIL
$97.6M
| $619K | ﹤0.01% |
53,430
+4,873
| +10% | +$56.5K |
|
4235
First Trust Morningstar Dividend Leaders Index Fund
FDL
$5.74B
| $619K | ﹤0.01% |
16,314
-8,261
| -34% | -$313K |
|
4236
SPDR DoubleLine Emerging Markets Fixed Income ETF
EMTL
$94.6M
| $619K | ﹤0.01% |
14,641
-45,897
| -76% | -$1.94M |
|
4237
SGHC Ltd
SGHC
$5.95B
| $618K | ﹤0.01% |
191,235
+102,861
| +116% | +$332K |
|
4238
iShares USD Green Bond ETF
BGRN
$422M
| $617K | ﹤0.01% |
13,261
-47,985
| -78% | -$2.23M |
|
4239
STAG Industrial
STAG
$6.53B
| $617K | ﹤0.01% |
+17,107
| New | +$617K |
|
4240
Invesco Electric Vehicle Metals Commodity Strategy No K-1 ETF
EVMT
$7.22M
| $617K | ﹤0.01% |
36,968
+10,488
| +40% | +$175K |
|
4241
V2X
VVX
$1.73B
| $616K | ﹤0.01% |
12,837
+4,940
| +63% | +$237K |
|
4242
Direxion NASDAQ-100 Equal Weighted Index Shares
QQQE
$1.23B
| $615K | ﹤0.01% |
6,932
-17,258
| -71% | -$1.53M |
|
4243
ARKO Corp
ARKO
$545M
| $614K | ﹤0.01% |
97,906
+26,225
| +37% | +$164K |
|
4244
RAPT Therapeutics
RAPT
$328M
| $613K | ﹤0.01% |
25,127
+10,031
| +66% | +$245K |
|
4245
Insteel Industries
IIIN
$747M
| $612K | ﹤0.01% |
+19,777
| New | +$612K |
|
4246
Wintrust Financial
WTFC
$9.04B
| $612K | ﹤0.01% |
6,209
-2,091
| -25% | -$206K |
|
4247
Cullen Enhanced Equity Income ETF
DIVP
$32.9M
| $610K | ﹤0.01% |
24,440
-50,443
| -67% | -$1.26M |
|
4248
LivePerson
LPSN
$97.5M
| $610K | ﹤0.01% |
1,051,205
+726,648
| +224% | +$422K |
|
4249
Kodak
KODK
$500M
| $610K | ﹤0.01% |
113,400
+88,768
| +360% | +$478K |
|
4250
C4 Therapeutics
CCCC
$225M
| $609K | ﹤0.01% |
131,866
+77,752
| +144% | +$359K |
|